Josh Uppal

Bachelor of Medicine and Bachelor of Science,  Cleveland Clinic 

Location: United States

Consulting Services

Research Consulting Data Science-Bioinformatics Hospital-Pharmacy-Insurance Pharma-CRO-Device

Areas Of Interest

Dilation, Gastric beta Aspartate Saquinavir CRE-BPa Transcription Factor Drusen, Optic Nerve Phase, Lunar Interferon alpha beta Receptor IFNAR1 Subunit Antigen CD94 Trinitrobenzenesulfonic Acid, Sodium Salt RNA Phages Pyocyanin Kumquats Arguloidas Larchs Xamoterol Maleate (2:1) Cytochrome P 450 Steroid 27 Hydroxylase Disthelm Refinement, Rietveld gamma-Melanotropin Heat Stress Transcription Factors Vitex Oxidoreductase, Succinate-Q Deficiency Disease, Hypoxanthine Phosphoribosyl Transferase Intermediate Concussion Calcium 40 Fisifax Pacemakers, Biologic Noscapine Axonal Bundling Uridyltransferase, Galactose-1-Phosphate DNA Mutational Analysis Inflammatory Pulmonary Pseudotumor Diphenylacetic Acids Botulinum A Toxin Occupation, Allied Health Implant, Bioabsorbable

Professional Narrative

Dr. Josh Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 2002
Medical Writer, Mayo Clinic 2006

Education

Doctor of medicine, Baylor College 2004
Doctor of medicine, Harvard Medical School 1997

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :